RWM
MRNA icon

Ritholtz Wealth Management’s Moderna MRNA Stock Holding History

Ritholtz Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,122
Closed -$219K – 779
2023
Q3 		$219K Buy
2,122
+452
+27% +$50.4K 0.01% 634
2023
Q2 		$203K Buy
1,670
+145
+10% +$19.3K 0.01% 619
2023
Q1 		$234K Sell
1,525
-713
-32% -$118K 0.01% 578
2022
Q4 		$402K Sell
2,238
-1,069
-32% -$175K 0.02% 404
2022
Q3 		$391K Buy
+3,307
New +$502K 0.02% 464
2022
Q2 		– Sell
-1,350
Closed -$233K – 580
2022
Q1 		$233K Buy
1,350
+15
+1% +$2.52K 0.02% 471
2021
Q4 		$339K Sell
1,335
-61
-4% -$17.8K 0.02% 385
2021
Q3 		$537K Buy
+1,396
New +$515K 0.04% 255

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ritholtz Wealth Management's MRNA Position: Q4 2023 in Review

Ritholtz Wealth Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 2,122 shares — an estimated $219K sold.

Ritholtz Wealth Management first reported a position in MRNA in Q3 2021 and held it in 8 quarters. The position peaked at $537K in Q3 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Ritholtz Wealth Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Ritholtz Wealth Management sold 2,122 Moderna shares in Q4 2023, an estimated $219K.
  • Ritholtz Wealth Management first reported a position in Moderna in Q3 2021 and held it in 8 quarters.
  • Ritholtz Wealth Management's Moderna position peaked at $537K in Q3 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Ritholtz Wealth Management's 13F filing for Q4 2023, filed 18 Jan 2024.